Clinical trial
Prospective Controlled Study of the Efficacy of NdYag for Hidradenitis Suppurativa
NCT00494351 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Controlled Study of the Efficacy of NdYag for Hidradenitis Suppurativa
- Lead sponsor
- Henry Ford Health System
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- July 31, 2009
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.